Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
published in: The Lancet
date of publication: 2007-06-01
language: English
main subject: phase I clinical trial, gene therapy, Parkinson's disease, virus
Cites articles 27
- 2000-11-01
- 1998-10-08
Date
Title
Article - wd:Q34640765